FDA Announces Public Meeting of Pediatric Oncology Subcommittee of Oncologic Drugs Advisory Committee

Summary

The FDA is hosting a public meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee to gather public input on regulatory issues, with the meeting open to the public and a public docket established for comments.